Bioventus (BVS) Inventory (2020 - 2026)

Bioventus' Inventory history runs 7 years deep, the most recent figure standing at $83.2 million for Q1 2026.

• Quarterly Inventory fell 11.55% year-over-year to $83.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83.2 million (down 11.55% YoY) and the FY2025 annual result came in at $82.2 million, down 11.07% from the prior year.
• Inventory was $83.2 million for Q1 2026 at Bioventus, up from $82.2 million in the prior quarter.
• Across five years, Inventory topped out at $97.6 million in Q3 2023 and bottomed at $64.7 million in Q2 2022.
• A 5-year average of $87.5 million and a median of $90.0 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory jumped 110.45% — and 2026, when it dropped 11.55%.
• Bioventus' Inventory stood at $84.8 million in 2022, then grew by 7.75% to $91.3 million in 2023, then grew by 1.25% to $92.5 million in 2024, then retreated by 11.07% to $82.2 million in 2025, then increased by 1.16% to $83.2 million in 2026.
• Business Quant data shows BVS's Inventory at $83.2 million in Q1 2026, $82.2 million in Q4 2025, and $96.3 million in Q3 2025.